Trial Profile
Soluble interleukin-2 receptor levels and CD4/CD8 ratio as predictors of response to abatacept in biological-naive patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 16 Dec 2015 New trial record